Search Result "L-Dopa-induced dyskinesias"
mGlu5, Dopamine D2 and Adenosine A2A Receptors in L-DOPA-induced Dyskinesias
Journal: Current Neuropharmacology
Volume: 14 Issue: 5 Year: 2016 Page: 481-493
Author(s): Nicolas Morin,Marc Morissette,Laurent Grégoire,Thérèse Di Paolo
Receptor Heteromers in Parkinsonâs Disease and L-DOPA-Induced Dyskinesia
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12 Issue: 8 Year: 2013 Page: 1101-1113
Author(s): Chiara Fiorentini,Paola Savoia,Daria Savoldi,Cristina Missale
Role of Nitric Oxide in Motor Control: Implications for Parkinsons Disease Pathophysiology and Treatment
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 5 Year: 2011 Page: 471-488
Author(s): Elaine Del-Bel, Fernando Eduardo Padovan-Neto, Rita Raisman-Vozari, Marcio Lazzarini
Tardive Dyskinesia with Atypical Antipsychotic Drugs
Journal: Current Drug Therapy
Volume: 2 Issue: 3 Year: 2007 Page: 168-176
Author(s): Jambur Ananth, Kartik Ananth, Aparna Keshavan
Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinsons Disease
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 6 Year: 2011 Page: 670-684
Author(s): M. A. Cenci, K. E. Ohlin, P. Odin
L-DOPA and Serotonergic Neurons: Functional Implication and Therapeutic Perspectives in Parkinsons Disease
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 11 Issue: 4 Year: 2011 Page: 305-320
Author(s): Sylvia Navailles, Manolo Carta, Martin Guthrie, Philippe De Deurwaerdere
Aminochrome as New Preclinical Model to Find New Pharmacological Treatment that Stop the Development of Parkinsonâs Disease
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 4 Year: 2016 Page: 346-359
Author(s): Juan Segura-Aguilar,Patricia Muñoz,Irmgard Paris
Therapeutic Potential of Natural Products in Parkinsonâs Disease
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 6 Issue: 3 Year: 2012 Page: 181-200
Author(s): Rajeswara B. Mythri,Gangadharappa Harish,M. M. Bharath
Prime Time for G-Protein-Coupled Receptor Heteromers as Therapeutic Targets for CNS disorders: The Dopamine D1-D3 Receptor Heteromer
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 5 Year: 2010 Page: 596-600
Author(s): Sergi Ferre, Carmen Lluis, Jose Luis Lanciego, Rafael Franco
Recent Progress in Gene Therapy for Parkinsonâs Disease
Journal: Current Molecular Medicine
Volume: 12 Issue: 10 Year: 2012 Page: 1311-1318
Author(s): Y. Nakata,T. Yasuda,H. Mochizuki